Nature’s Sunshine Reports Strong Q1 2025 Results

Nature’s Sunshine (Nasdaq: NATR), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025.

Q1 2025 Financial Summary vs. Same Year-Ago Quarter

• Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).
• GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.
• Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million.

“2025 got off to a strong start, as first quarter revenue came in at $113 million, up 5% on a constant currency basis, and adjusted EBITDA came in at $11 million, up 20% versus prior year,”

said Terrence Moorehead, CEO of Nature’s Sunshine.

“We’re particularly pleased with the exceptional growth we’re seeing in Asia and Europe where markets like Taiwan, Japan and Central Europe continue to deliver strong double-digit growth. We’re also pleased to see early signs of stabilization in North America and continued improvements to gross margin. Despite the tremendous amount of uncertainty in the market, we remain confident in the underlying health of our business, and our performance reflects the power of our global growth strategies. In addition, our Board has authorized the repurchase of up to $25 million in common stock, supplementing the $8.3 million remaining under the current authorization, as we continue to make disciplined investments with the highest potential return for our shareholders.”

First Quarter 2025 Financial Results

	Net Sales by Operating Segment (Amounts in Thousands):
Three Months Ended March 31,		2025				2024				Percent Change			Impact of Currency Exchange				Percent Change Excluding Impact of Currency
Asia		$	48,653			$	46,220			5.3	%		$	(2,214)			10.1	%
Europe			24,114				22,296			8.2				(90)			8.6
North America			35,018				36,525			(4.1)				(166)			(3.7)
Latin America and Other			5,463				5,952			(8.2)				(271)			(3.7)
		$	113,248			$	110,993			2.0	%		$	(2,741)			4.5	%

Net sales in the first quarter increased 2% to $113.2 million compared to $111.0 million in the same year-ago quarter. Excluding the impact from foreign exchange rates, net sales in the first quarter of 2025 increased 5% compared to the year-ago quarter.

Gross profit margin in the first quarter increased to 72.1% compared to 71.2% in the year-ago quarter. The increase was driven by price increases and effective savings initiatives.

Net cash provided by operating activities was $2.6 million for the three months ended March 31, 2025, compared to $2.2 million in the prior year period. Capital expenditures during the three months ended March 31, 2025, totaled $1.1 million compared to $3.7 million in the comparable period of 2024. During the three months ended March 31, 2025, the Company repurchased 38,000 shares at a total cost of $0.5 million or $12.47 per share. As of March 31, 2025, the Company had cash and cash equivalents of $86.5 million and zero debt.

About Nature’s Sunshine Products

Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today.